Glasgow-headquartered clinical research facility, NeuroClin, has appointed Fiona Wood as its new CEO and confirmed an agreement has been reached to open a new site in North West England this Autumn.
The Sustainable Aquaculture Innovation Centre (SAIC) has secured new funding to continue its support of fish health research and development (R&D), delivered in collaboration between the private and public sectors.
Nebu-Flow, a University of Glasgow spinout developing next-generation inhaled drugs for respiratory disorders, has secured an additional £4.7 million investment.
Phlo has announced the close of a £9 million funding round, accessing additional investment for their group of businesses amid a challenging investor market.
Scottish biopharmaceutical firm EnteroBiotix has raised over £27 million from new and existing investors, positioning it to expand and accelerate its pioneering work in developing microbiome medicines.
Scottish-based PhaSER Biomedical (PhaSER) has agreed a long-term partnership with the Sanders Tri-Institutional Therapeutic Discovery Institute, Inc. (TDI) to enhance the institute’s groundbreaking pre-clinical drug discovery research.
Scotland’s thriving life sciences sector needs increased investment in top-quality lab and research facilities to sustain growth, according to real estate advisor CBRE.
The Industrial Biotechnology Innovation Centre (IBioIC) has supported the growth of Scotland’s industrial biotechnology sector by helping it to attract £35 million of additional funding for research and development, according to new figures revealed to mark its 10th anniversary.
Kedras Clinics, a neurotechnology-focused wellbeing therapy provider, has successfully secured a £50,000 loan from the British Business Bank’s Investment Fund for Scotland, Smaller Loans fund.
A breakthrough class of molecular glue identified at the University of Dundee could pave the way for a new generation of drugs to target cancers and neurodegenerative diseases.